The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
CASTLE BIOSCIENCES INC | COM | 00773J103 | 347,798 | 20,592 | SH | SOLE | 20,592 | 0 | 0 | ||
SONENDO INC | COM | 835431107 | 408,657 | 547,945 | SH | SOLE | 547,945 | 0 | 0 | ||
PRENETICS GLOBAL LTD | CLASS A ORD | G72245106 | 12,125 | 25,000 | SH | SOLE | 25,000 | 0 | 0 | ||
PYXIS ONCOLOGY INC | COMMON STOCK | 747324101 | 137,912 | 69,303 | SH | SOLE | 69,303 | 0 | 0 | ||
SAGIMET BIOSCIENCES INC | COM SER A | 786700104 | 503,272 | 57,190 | SH | SOLE | 57,190 | 0 | 0 |